Internal Reference Number: FOI_6671
Date Request Received: 08/07/2022 00:00:00
Date Request Replied To: 03/08/2022 00:00:00
This response was sent via: By Email
Request Summary: Breast Cancer
Request Category: Private Individuals
| Question Number 1: In the past 3 months, how many Breast Cancer patients (any stage) were treated with: i) Abemaciclib monotherapy ii) Aromatase inhibitor monotherapy (e.g. anastrazole, exemestane, letrozole) iii) Tamoxifen monotherapy iv) Abemaciclib + Tamoxifen v) Abemaciclib + Tamoxifen + Goserelin vi) Abemaciclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole) + Goserelin vii) Aromatase inhibitor + Goserelin viii) Tamoxifen+ Goserelin | |
| Answer To Question 1: 1) Abemaciclim monotherapy 0 2) Aromatase inhibitor monotherapy – Information not held or recorded by the Trust in a reportable format 3) Tamoxifen- Information not held or recorded by the Trust in a reportable format 4) Abemaciclib+ tamoxifen- 0 5) Abemaciclib + aromatase inhibitor- 0 6) Aromatase inhibitor + goserelin- Information not held or recorded by the Trust in a reportable format 7) Tamoxifen + goserelin- Information not held or recorded by the Trust in a reportable format | |
| Question Number 2: How many patients have been treated for Triple-Negative Breast Cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies: i) Anthracycline (e.g. doxorubicin or epirubicin) as a single agent ii) Atezolizumab +Nab-paclitaxel/Paclitaxel iii) Pembrolizumab iv) Sacituzumab Govitecan v) Parp Inhibitors (Olaparib/Talazoparib) vi) Eribulin as a single agent or in combination vii) Capecitabine as a single agent viii) Platinum (e.g. carboplatin or cisplatin) as a single agent ix) Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent x) Taxane and/or Anthracycline in combination xi) Any other active systemic anti-cancer therapy | |
| Answer To Question 2: x) taxane and anthracycline <5. For all others 0 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
